Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% sodium alendronate gel for periodontal lesions
IRCT20260425069158N1Phase 3Recruiting
- Sponsor
- Babol University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of alendronate in chronic periodontitis (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Clinical Attachment Level, Gingival Index and 1 more. Started May 2026; status: recruiting.
02
Drugs
alendronate
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on IRCT20260425069158N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260425069158N1.